WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.
about
How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western CountriesQuantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household studyNeonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.Clinical Predictors of Critical Lower Respiratory Tract Illness Due to Respiratory Syncytial Virus in Infants and Children: Data to Inform Case Definitions for Efficacy Trials.Estimates of influenza and respiratory syncytial virus incidences with fraction modeling approach in Baguio City, the Philippines, 2012-2014Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.Vaccines against respiratory syncytial virus: The time has finally come.Respiratory syncytial virus infection in infants in rural Nepal.Antibody response to respiratory syncytial virus infection in children <18 months oldIterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.Immunogenicity of RSV F DNA Vaccine in BALB/c Mice.Vaccination strategies against respiratory syncytial virus.Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model.Necrotizing pneumonia: an emerging problem in children?Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.Respiratory virus detection during hospitalisation for lower respiratory tract infection in children under 2 years in South Auckland, New Zealand.Epidemiology of laboratory-confirmed respiratory syncytial virus infection in young children in England, 2010-2014: the importance of birth month.Acute respiratory infections in hospitalized children in Vientiane, Lao PDR - the importance of Respiratory Syncytial Virus.Passive and active immunization against respiratory syncytial virus for the young and old.Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing.Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies.Cytokine responses in primary and secondary respiratory syncytial virus infections.Virus vs. virus: adenovirus vectored vaccine to defeat respiratory syncytial virus.Vaccines Against Respiratory Syncytial Virus: The Time Has Come.Meeting Report: Harmonization of RSV therapeutics – from design to performanceIncidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015.Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016.Deciphering clinical phenotypes in acute viral lower respiratory tract infection: Bronchiolitis is not an island.Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study.Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England.
P2860
Q26748155-72039466-7D7F-4903-87A8-C6A0426A4D1DQ28069415-B9637156-857F-4EED-A1A2-F07B9B017D44Q28365074-E00FFABF-A700-4212-9252-AF3916F008E7Q31119651-19EB021E-2CE9-4E29-A48C-0A270856506FQ31132340-FD97094B-9C5B-4A45-8059-9167BE859DB5Q33838103-C786AC83-8F2D-4C9C-BC0B-BC4D1C33E3E5Q36973952-97F38130-93F9-498C-8A44-4266665DEEB3Q37018347-FD55995E-0715-48B7-80D4-76343E331D80Q37088637-725A58EF-C70E-423F-8A62-E6234898F8D3Q37135395-A2C03D7A-0636-4F3A-86E5-4A5A31A393F1Q37242530-49E27003-7C1B-42B6-9BE4-0D3E8897263CQ37263840-6899AC06-AA1E-4228-A6A9-8DEA00F72E05Q37469280-25C381FC-ACBC-4B28-865E-9C8FAB69992AQ37635077-657F92C6-666E-4547-A233-3187DCE631D6Q38645380-0091ACF4-53BD-45E8-BE3D-7C8C204EBDE5Q38687853-75E801D0-9440-493C-A406-130AFB7A68EAQ38826847-94B4B916-BAD8-4FB3-A5AC-6422D4F9384BQ38903197-24510873-DB33-431C-AED9-0816C705162CQ39302642-DA959DA0-473A-428F-BAE3-60D958F3C1EDQ39318498-B0918C44-8B2D-4A37-99CD-6B573D1C98E9Q40040542-5D163100-A83B-43EB-9B66-7497AB8DA8F5Q40043300-A44EF369-956E-4759-9533-B52D5FA296F0Q40062704-D4E892CE-B179-41AD-8175-15E6CA500B4CQ40072947-40C454B2-3D50-4984-B632-C8C1676C7EECQ40262485-164091C4-C7BE-4284-B4CA-664B29A9973BQ40370341-74F55994-4B02-40E1-8D81-58E1B0CCD472Q40789579-116E6558-BFBE-443B-80A2-1EC521E5FE87Q42330836-1358033A-35D6-4E21-A03C-E902D1B6865CQ45332913-6BFC0DF9-B968-4BEC-9EC2-26E6F4455B9BQ46622417-1F46EE38-004B-4BF0-9E1E-BC7789B6E585Q47547530-E2A0BD90-D62B-442F-A617-859FCA2E80CDQ49575441-9F6B9285-5947-4463-8474-BFDBFA5EB271Q50793129-625FA7A8-94DB-4FCA-856C-B50C98EB8B0AQ52728476-DB4B8E27-A5D9-497E-8022-FAE7DB4A20D0Q53693691-EC622031-FD54-4176-ACDC-0BB385B8939E
P2860
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
WHO consultation on Respirator ...... ting held on 23-24 March 2015.
@en
WHO consultation on Respirator ...... ting held on 23-24 March 2015.
@nl
type
label
WHO consultation on Respirator ...... ting held on 23-24 March 2015.
@en
WHO consultation on Respirator ...... ting held on 23-24 March 2015.
@nl
prefLabel
WHO consultation on Respirator ...... ting held on 23-24 March 2015.
@en
WHO consultation on Respirator ...... ting held on 23-24 March 2015.
@nl
P2093
P1433
P1476
WHO consultation on Respirator ...... eting held on 23-24 March 2015
@en
P2093
Birgitte Giersing
David C Kaslow
Kayvon Modjarrad
Vasee S Moorthy
WHO RSV Vaccine Consultation Expert Group
P304
P356
10.1016/J.VACCINE.2015.05.093
P407
P577
2015-06-20T00:00:00Z